The Song of the Cell

Siddhartha Mukherjee argues that medicine is becoming cellular — that a growing share of what we can treat is understood as a disorder of cells, and treated by replacing, engineering or retraining them rather than by drugging a pathway.

The book builds that case historically first. It starts with the invention of the microscope and the slow recognition that organisms are made of cells, then Rudolf Virchow's insight that disease is cellular pathology, which reframed illness as something happening in identifiable units rather than in humours or in the body as a whole. From there Mukherjee proceeds cell type by cell type — blood cells, immune cells, neurons, the cells of reproduction — pairing the biology of each with the clinical stories it produced: bone marrow transplantation, in vitro fertilisation, insulin-producing cell transplants, and CAR-T therapy, in which a patient's own T cells are genetically modified to attack their cancer. His own clinical experience runs through the later chapters.

It is for readers following cell and regenerative therapies, and for patients and families who want the conceptual background to treatments they are hearing about.

On the evidence: the history and the core cell biology are well-grounded, and the immunology is handled by someone who works in the field. The important distinction for a reader is that the forward-looking sections describe therapies at very different stages of proof. CAR-T is approved and established for specific blood cancers with documented outcomes. Much of the rest of cellular medicine — regenerative approaches, engineered tissues, many stem cell applications — remains investigational, and the gap between a compelling mechanism and a demonstrated clinical benefit is where most of this field currently sits. Read it for the arc of the idea. It is not a guide to what is available, advisable or ready.